MarketWatchCenter·
Novo Nordisk stock is sliding again — and the Wegovy pill’s surprise miss is partly to blame
The Danish drugmaker also revealed an improved outlook for the year.
Read at MarketWatch →
Markets · 1 sources covering this
Novo Nordisk stock is sliding again — and the Wegovy pill’s surprise miss is partly to blame
The Danish drugmaker also revealed an improved outlook for the year.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/b0d36789637e34c48c8b8f5b1d39dd9ba445d430" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Novo Nordisk stock is sliding again — and the Wegovy pill’s surprise miss is partly to blame"></iframe>
